Phthalates are suspected to disrupt the endocrine system, especially through estrogenic effects. In the present study, we investigated the effects of various phthalates and compared them with those of estrogenic compounds that disrupt the female reproductive system. To assess the effects of these phthalates, alteration of the Calbindin-D9k (CaBP-9k) gene was measured as a biomarker because rat CaBP-9k gene carries an estrogen response element (ERE) which is involved in estrogen responsiveness of the gene during the estrous cycle. In this study, phthalates were tested for estrogenic properties in in vitro and in vivo models. First, the E-Screen assay was used to measure the proliferation of MCF-7 cells, a human breast cancer cell line. Treatments with 17β-estradiol (E2; 9fold) and 17α-estradiol (EE; 9-fold) induced MCF-7 cell proliferation at concentrations of 10 -9 M. Phthalates induced an increase in MCF-7 proliferation at concentration of 10 -6 M up to 10 -4 M. Nbutyl benzyl phthalate (BBP; 6-fold vs. vehicle), dicyclohexyl phthalate (DCHP; 8-fold), 2-ethylhexyl phthalate (DEHP; 6-fold) and di-n-butyl phthalate (DBP; 7-fold) at the concentration of 10 -4 M induced in an increase in MCF-7 proliferation after 6 d of treatment compared to vehicle. However, significant increase in MCF-7 proliferation was induced by diethyl phthalate (DEP). Second, we investigated the expression of CaBP-9k in the uterus of immature rats after oral treatment with BBP, DCHP, DEHP, DBP or DBP (600 mg/kg per day) in this in vivo model, because the immature rat model is highly sensitive to exposure to estrogenic chemicals. None of the phthalates induced the expression of CaBP-9k mRNA and its protein in the neonatal uterus as analysed by Northern and Western blot analyses, respectively. Although phthalates induced an increase in MCF-7 cell proliferation by an estrogenic effect, they could not induce CaBP-9k expression in the in vivo system, suggesting that the assays of estrogenic effects of various phthalates conducted in vitro and in vivo expression of CaBP-9k may produce conflicting results.
hthalate esters are a group of compounds that are all diesters of phthalic acid, and they are mainly used as plasticizers in polyvinylchloride (PVC) plastics and to a lesser degree in paints, lacquers, pesticides, cosmetics, ammunition and lubricants [1, 2] . Phthalates are made abundantly by humans, and in the environment they are suspected of disrupting the endocrine system [2] . They have been reported to have estrogenic activities which mimic endogenous estrogen [3, 4] . Recently, it has been suggested that some endocrine disrupters may also contribute to the development of hormonedependent cancers, such as breast and endometrial cancers [5, 6] . Phthalate plasticizers contain butyl benzyl phthalate (BBP), dicyclohexyl phthalate (DCHP), diethyl phthalate (DEP), 2-ethylhexyl phthalate (DEHP) and di-nbutyl phthalate (DBP). The measurement of phthalate concentrations in out-and in-door atmospheres, especially, phthalates in new buildins that DEHP and DBP abundantly exist, and small amounts of DEP, BBP and DCHP were also detected [7] .
Previous studies have demonstrated that endocrine disrupters, e.g. BBP, are capable of interacting with estrogen receptors (ERs) and induce ER-mediated responses, suggesting that estrogenic or anti-estrogenic effects elicited by these substances may be receptor-mediated [5, 6, 8, 9] . BBP showed an estrogenic activity in several in vitro tests: MCF-7 cell proliferation, ER binding in the rat uterus, and yeasts transfected with human ER gene constrait [2, 5, 8, 10] . These in vitro tests can be useful for rapid identification of suspected compounds. An E-screen method using the MCF-7 breast cancer cell line is one of the most sensitive assays for assessing the estrogenic activity of several phthalates [11] . In addition, BBP and DBP are estrogenic in the yeast screen test and the mitogenic test using MCF-7 cells [2] . DEHP at a concentration of 10 -5 M induced an increase in proliferation of MCF-7 cells [1] . Di-n-alkyl phthalates such as BBP, DBP and DEHP have estrogenic activity that mimics the steroid A ring of receptorbinding modes of dialkyl phthalates [12] . On the other hand, DBP and DEHP did not show any estrogenic activity, as measured by a reporter gene assay (yeast two-hybrid system) and competition assay (fluorescence polarization system) [13] .
A synthetic estrogen diethylstilbestrol (DES) is one of the most widely studied endocrine disruptors. Endocrine activity has been observed by using DES in a wide dose range in all species. It is well documented that DES induces various reproductive alterations in humans [14] [15] [16] and mice [17] [18] [19] . Numerous reproductive changes in wildlife populations can be caused by endocrine disruptors [20] . The binding affinity of estrogenic compounds such as octylphenol (OP) and bisphenol A (BPA) to ER has been shown to be approximately 10 -3~1 0 -7 less than that of E2 [21] [22] [23] .
In female rats, subcutaneous OP induces an estrogen-like effect in the reproductive system, as evidenced by alterations in the estrous cycle and increases uterine weight [24, 25] . Recent studies have shed light on BPA and its potential for estrogen-like activity [26, 27] , and have confirmed its estrogen-like activity in vitro; BPA was estimated as approximately 15,000-fold less potent than E2 [28] . In addition, it has been demonstrated that BPA could interact with both ERα and ERβ [29] . In vitro binding studies have indicated that the binding affinity of BPA is approximately 10,000fold less potent than that of E2 and 20,000-fold less potent than DES for both ERα and ERβ [30] . Calbindin-D 9 k (CaBP-9k) is a vitamin Ddependent calcium-binding protein, which belongs to a group of intracellular proteins that bind calcium with high affinity and is localized in the mammalian intestine and uterus [31, 32] . The genes encoding not only rodent CaBP-9k but also human CaBP-9k have been cloned, and the complete sequence was established in our previous reports [33, 34] . In the uterus of rats, it has been demonstrated that CaBP-9k gene expression is highly regulated by E2, and is known to fluctuate during the estrous cycle of rats when the serum E2 level is also fluctuating [35] . At diestrus, CaBP-9k mRNA is not detectable, whereas at proestrus, its mRNA level increases and it reaches its highest level at estrus and then decreases as the cycle enters metestrus. In previous reports, we suggested that the expression of CaBP-9k mRNA and protein might be a novel biomarker for estrogenic compounds in the uterus of immature rats [36] [37] [38] [39] [40] . Thus, in the present study, we assessed the estrogenic activity of diverse phthalates using in vitro (E-screen test) and in vivo models related to the expression of CaBP-9k mRNA and protein in the uterus of rats, and compared their estrogenic activity with other potential estrogenic chemicals, such as DES, OP and BPA, to investigate the effect of these phthalates in the uterus of neonates following oral treatment with these compounds.
Materials and Methods
Chemicals 17β-Estradiol (E2), 17α-estradiol (EE), butyl benzyl phthalate (BBP, 98%), dicyclohexyl phthalate (DCHP), diethyl phthalate (DEP, 99.5%), and 2-ethylhexyl phthalate (DEHP, 99%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Di-n-butyl phthalate (DBP, 99%) was a product of Fluka (Sigma-Aldrich). In addition, octylphenol (OP) and bisphenol A (BPA) were purchased from Sigma-Aldrich in this study ( Fig.  1 ).
MCF-7 cell culture and cell proliferation assay in vitro
MCF-7 cells were maintained in 25-cm 2 cell culture flasks in full-medium consisting of Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 5% (v/v) heat inactivated fetal bovine serum (FBS; Gibco BRL). The cells were maintained in a humidified incubator at 37 C and 5% CO 2 over a maximum of 12 passages, and routinely tested for mycoplasma. The cell proliferation assay was a modification of that by Soto et al. [11] . A 70% confluent 25-cm 2 lask of MCF-7 cells was washed with 5 ml phosphate buffered saline (PBS) before the addition of 3 ml of Trypsin-EDTA (0.05 % trypsin and 0.53 mM EDTA; Gibco BRL). The flask was left for 1 min at room temperature after which the cells were detached by a firm slap and resuspended in 10 ml of full medium. MCF-7 cells were counted using an improved Neubauer counting chamber and seeded to 96-well plates at a density of 5 × 10 3 cells per well in 100 µl of full medium. After 24 h the cells were washed with 100 µl PBS. The medium was changed to 100 µl of estrogen-free medium (phenol red-free DMEM with 5% charcoal dextran-stripped human serum (CDHuS) for 48 h. After washing with PBS, the compounds were dissolved in DMSO, diluted with phenol-red free DMEM and added to the well. All groups were treated with the compounds for 6 days, and the cell numbers were estimated with cell counting kit-8 (Dojindo Laboratories, Kumamoto, Japan) by measuring fluorescence, which parallels the amount of nucleic acids. The experiments were repeated 3 times (each time n=5), and the values were presented as percentages compared to the control with 0.1% DMSO alone.
Treatment in vivo
Immature fem ale rats (Sprague D aw ley, purchased at 7 days old) were obtained from Dae Han Biolink Co., Ltd. (Chungbuk, Korea). All animals were housed in polycarbonate cages, and used after acclimation to an environmentally controlled room (temperature: 23 ± 2 C, relative humidity: 50 ± 10%, frequent ventilation and 12 h light cycle). They were fed with soy-free pellet food (Dyets Inc., Beth lehem, PA, USA). In the experiment, groups of five animals were each given an oral injection of OP, BPA, BBP, DCHP, DEP, DEHP or DBP at the dose of 600 mg/kg body weight (BW) per day dissolved in corn oil (Sigma-Aldrich) on days 14, 15 and 16 after birth and euthanatized on day 17. As positive controls, rats were given EE (50 µg/kg BW) or DES (500 µg/kg).
As a negative control group, rats were given corn oil for the same period of time. All experimental procedures and animal use were approved by the Approval of Ethics Committee of Chungbuk National University.
Northern blot analysis
Northern blot analysis was performed to determine CaBP-9k mRNA as described previously [38] [39] [40] . Briefly, 10-20 µg total RNA isolated from the uterus were electrophoresed and 18S rRNA used as an indicator of quantity of total RNA. The RNA was transferred overnight onto a nylon membrane (Schlicher and Schuell, Dassel, German), UV cross-linked, and prehybridized in buffer containing 50% formamide, 5 × Denhardt's solution (0.1% polyvinyl pyrrolidine, 0.1% BSA and 0.1% Ficoll), 5 × SSPE, 0.1% SDS and denatured salmon sperm DNA (100 µg/ml) for 2 h at 42 C before adding labeled probe. The cDNAs of CaBP-9k were l a b e l e d w i t h [ 3 2 P ] d C T P ( 3 , 0 0 0 C i / m m o l ; Amersham, Piscataway, NJ, USA) using the Random-Primed DNA labeling kit (Takara, Kyoto, J a p a n ) a n d p u r i f i e d a s i n d i c a t e d i n t h e manufacturer's protocol. Hybridization was performed in the fresh buffer at 42 C for 18 h with 32 P -labeled cDNA. After washing under stringent conditions, the membrane was exposed to Kodak X-AR film (Eastman Kodak, Rochester, NY, USA) at -80 C.
Western blot analysis
Immature rats were euthanatized by cervical dislocation, and the uterus was rapidly excised, and washed in cold sterile 0.9% NaCl. Protein was extracted with Proprep (Intron Co., Seoul, Korea) according to the supplier's instructions. Cytosolic protein (40 µg) per lane was dissolved by SDS-PAGE (15% acrylamide) and was transferred to nitrocellulose membrane by a Semi-dry transfer cell (Bio-Rad Co., Hercules, CA, USA) according to the manufacturer's protocol. The membranes were then blocked with phosphate-buffered saline containing 0.05% Tween-20 and 5% dry milk overnight and then incubated sequentially with primary and secondary antibodies dissolved in 1% BSA for 1 h at room temperature. In order to detect CaBP-9k protein, a polyclonal antibody (Swant, Bellinzona, Switzerland) against rat CaBP-9k was employed, and beta-actin antibody (42 kD, Santa Cruz Biotechnology, Santacruz, CA, USA) was used as an indicator of quantity of total protein. Horseradish peroxidase conjugated anti-rabbit IgG (Santa Cruz Biotechnology) was used as a second antibody.
Data analysis
Data are presented as the mean ± SD. The data were analyzed by the nonparametric procedure of the Kruskal-Wallis test, followed by Dunnett's test for two-pair comparisons. Each value of Dunnett's test was converted to rank for statistical analysis. All statistical analyses were performed with SAS. P<0.05 was considered statistically significant.
Results

Proliferative responses in MCF-7 cells
To determine whether phthalates mimic an estrogenic effect in cell proliferation, the potential ability of phthalates to promote anchoragedependent growth of MCF-7 cells was determined. T h e c e l l s w e r e t r e a t e d w i t h a r a n g e o f concentrations of the chemicals according to a protocol originally devised by Soto et al. [11] , and the numbers of cells were counted at different times. Both E2 (9-fold) and EE (9-fold) induced MCF-7 cell proliferation at a concentration of 10 -9 M. Treatments with BBP (6-fold), DCHP (8-fold), D E H P ( 6 -f o l d ) , a n d D B P ( 7 -f o l d ) a t h i g h concentration (10 -4 M) significantly stimulated the growth of MCF-7 cells compared to vehicle in estrogen-depleted medium (Fig. 2 ). In addition, treatment with BBP or DCHP at a concentration of 10 -5 M resulted in 8-fold or 5-fold increases in cell numbers after 6 days compared to the vehicle, respectively. No significant increase of cell growth was observed by the treatment with DEP. When the cells were treated with 17α-ethynylestradiol and phthalates, there was a synergistic effect on cell growth (P<0.05).
Expression of CaBP-9k mRNA and protein following treatment with phthalates
Neonatal rats were injected with phthalates to determine their estrogenic effect on the induction of CaBP-9k mRNA in the uterus by Northern blot analysis. The expression level of CaBP-9k mRNA in the neonatal uterus was significantly increased by treatment with 50 µg/kg BW per day of EE (21-fold vs. vehicle) for 3 days. However, oral treatment with 600 mg/kg BW per day of BBP, DCHP, DEP, DEHP, or DBP for 3 days did not increase the expression level of CaBP-9k mRNA (Fig. 3 ). In addition, the expression level of CaBP-9k mRNA in the uterus was not significantly increased when treated with phthalates at different doses (200 and 400 mg/kg BW per day) for 3 days (data not shown).
In parallel to the CaBP-9k mRNA level, the expression level of CaBP-9k protein was examined in the neonatal uterus by immunoblot analysis following oral injection with phthalates. Treatment with phthalates (600 mg/kg BW per day) did not induce CaBP-9k protein, while a single treatment with EE (50 µg/kg BW per day) resulted in an increase of CaBP-9k protein (14-fold vs. vehicle) as shown in Fig. 4 . In addition, treatments with lower doses of phthalates (200 and 400 mg/kg BW per day) did not induce the expression of CaBP-9k protein in the uterus of immature rats (Data not shown).
Induction of CaBP-9k mRNA and protein following treatment with estrogenic compounds
In the neonatal uterus, treatment with a high dose (600 mg/kg BW) of OP and BPA resulted in induction of CaBP-9k mRNA, as did single dose treatments of EE or DES (Fig. 5 ). An increased expression level of CaBP-9k mRNA was observed in treatments with a high dose (600 mg/kg BW per day) for 3 days of OP (11-fold) or BPA (10-fold), and a single dose treatment with EE (14-fold, 50 µg/kg BW) or DES (17-fold, 500 µg/kg BW per day) as demonstrated in Fig. 5 . Furthermore, treatments of immature rats with lower doses of OP and BPA (200 and 400 mg/kg BW) for 3 days also increased the expression level of CaBP-9k mRNA (data not shown).
Using Western blot analysis, we further examined the expression levels of CaBP-9k protein in the neonatal uterus following oral injections with EE, DES, OP or BPA. The expression levels of neonatal CaBP-9k protein were significantly increased after treatment with a high dose of OP (5fold, 600 mg/kg BW per day) or BPA (5-fold, 600 mg/kg BW per day) as shown in Fig. 6 . In addition, single doses of EE (5-fold, 50 µg/kg BW) or DES (5fold, 500 µg/kg BW) induced a significant increase in CaBP-9k protein (Fig. 6 ).
Discussion
Nowadays, phthalates are produced in large amounts because of their widespread use in the plastic, PVC, for a vast number of technical purposes and some food contact materials [41, 42] . Phthalates are ubiquitous environmental contaminants, and have been detected in sediment, water, and air [43] .
It has been reported that there is a relationship between the structure of a chemical and its estrogenic activity, and estrogenic effect results from a phenolic ring [44] . However, it is unclear what kind of chemical structure is needed for binding to ERs. In the present study, we clearly demonstrated that phthalates are group of chemicals involved in estrogenic activities as observed in the in vitro assay using MCF-7 cells. However, other researchers have reported a non-estrogenic effect, concluding that phthalates in vivo did not induce increases in uterine weights and the keratinization of vaginal epithelial cells in rats [2, 8] . In this study, the expression level of CaBP-9k mRNA and protein in the neonatal uterus were not increased by phthalates, suggesting that phthalates may not have an estrogenic effect in terms of the expression level of the CaBP-9k gene as a biomarker unlike estrogenic compounds such as DES, OP and BPA.
To explore whether or not phthalates have estrogenic activity affecting cell proliferation, the proliferation of MCF-7 cells was estimated after 6day treatment of cells with test compounds. As Briefly, 40 µg of protein were electrophoresed on SDS-PAGE and transferred to nitrocellulose membrane. The membranes were hybridized with an antiserum to rat CaBP-9k and exposed to Xray film. The values represent means + SD. a, P<0.05 vs. vehicle control. expected, EE increased the proliferation of MCF-7 cells, in addition, the phthalates, BBP, DCHP, DEHP and DBP, significantly stimulated the growth of MCF-7 cells compared to control, though DEP did not. BBP has been reported to be an estrogenic compound and to be a partial agonist for ER [5, 8, 10] . Xenoestrogens such as methoxychlor require metabolic activation to become estrogenic, whereas other compounds may themselves be estrogenic and be deactivated by metabolism [45] . When metabolized 90%, BBP breaks down within 48 h into the mono-esters, mono-n-butyl phthalate, mono-n-benzyl phthalate, phthalic acid and benzoic acid [9] . None of these metabolites have shown estrogenic activity in not only the E-Screen assay, but also the recombinant yeast screen [2, 46] . In other di-n -alkyl pht halates, the lowest concentration that significantly increased the proliferation of MCF-7 cells was 10 µM of DEHP, which has proved to be a valuable tool for screening potential estrogen-mimicking environmental pollutants [1] . Although there was poor evidence for the mechanism of proliferation, it is likely that estrogenic response is caused via not only ER, but also other unknown factors [47] . Some phthalate esters (DBP and BBP) exhibit weak ER-mediated activity in in vitro assays at high concentrations, but none elicited in vivo estrogenic responses as indicated by the results obtained from uterotrophic and vaginal cornification assays in ovariectomized female Sprague-Dawley rats [8, 48] . Various phthalates were examined for estrogenic effects by the expression of CaBP-9k gene in this study, because some false-positive responses can be found in the E-Screen assay [49] . The CaBP-9k gene is a novel biomarker for estrogenic compounds using the uterus of immature rats as shown by our previous studies [36] [37] [38] [39] [40] . Based on those, the present study was performed to further investigate the estrogenic effects of phthalates compared to estrogenic compounds in the uterus of neonatal rats. The expression levels of CaBP-9k mRNA and protein were analyzed following treatments with various phthalates to investigate the estrogenic activity in vivo by Northern blot and Western blot analyses. Different from expectation, oral treatment with phthalates for 3 days did not induce the expression of CaBP-9k mRNA and protein. Expression of CaBP-9k gene is predominantly controlled by estrogen in the rat uterus [20, [50] [51] [52] . E2 stimulates the transcription of the CaBP-9k gene in the uterus of mature ovariectomized and immature rats [20] . It appears that none of the phthalates used in the present study significantly increase CaBP-9k mRNA and protein in the uterus. However, a single dose of EE and DES resulted in an increase of CaBP-9k mRNA and protein in the neonatal uterus. Furthermore, treatment with OP and BPA for 3 days resulted in an increase of CaBP-9k in uterine tissue, indicating that these estrogenic compounds affect reproductive tissues by the induction of CaBP-9k mRNA and protein. The difference of estrogenic activity between phthalates and estrogenic compounds in reproductive tissue suggests that phthalates may be metabolized and deprived of estrogenic activity in this tissue [8, 9] . Consistent with previous reports, a significant increase in the uterine wet weight was observed after treatment with OP in a dose-dependent manner. A good correlation between in vivo u t e r o t r o p i c r es p o n s e a n d C a B P -9 k m R N A expression, which is regulated through the binding of ER/estrogen complex to estrogen response element (ERE), was also observed [36] . It was previously reported that BPA is active at high doses (400-800 mg/kg) in uterotropic assays in immature AP rats in either oral or subcutaneous administration [53] . In the present study, BPA induced a strong CaBP-9k expression at highest dose and showed a clear estrogen-like action in the induction of the CaBP-9k gene. Among the assays for the estrogenic activity of chemicals, an assay to detect endogenous gene expression that measures estrogen-induced changes either in cultured cells or in selected tissues from exposed animals has been proposed and is widely being used. In the present study, we demonstrated that phthalate esters exhibit weak estrogenic activity in in vitro assays at high concentrations. Although phthalates induced an increase in MCF-7 cell proliferation by an estrogenic effect, they could not induce CaBP-9k expression in vivo following oral treatments, suggesting that these phthalates are easily metabolized to inactive forms in vivo. Taken together, we conclude that the assays estrogenic effects of various phthalates conducted in vitro and in vivo using the expression of CaBP-9k may produce conflicting results.
